These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 7101237

  • 1. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
    Poon MC, Hurst RE, Rives MS.
    Thromb Haemost; 1982 Apr 30; 47(2):162-5. PubMed ID: 7101237
    [Abstract] [Full Text] [Related]

  • 2. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J, Hoppensteadt DA, Cornelli U, Manoni M, Fareed J.
    Clin Appl Thromb Hemost; 2007 Jan 30; 13(1):52-64. PubMed ID: 17164496
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of recombinant platelet factor 4 and protamine sulfate for heparin neutralization: clotting and clearance studies in rat.
    Korutla LN, Stewart GJ, Lasz EC, Maione TE, Niewiarowski S.
    Thromb Haemost; 1994 May 30; 71(5):609-14. PubMed ID: 8091389
    [Abstract] [Full Text] [Related]

  • 4. Interrelationship of protamine and platelet factor 4 in the neutralization of heparin.
    Shanberge JN, Quattrociocchi-Longe TM, Martens MH.
    Thromb Res; 1987 Apr 01; 46(1):89-100. PubMed ID: 3590116
    [Abstract] [Full Text] [Related]

  • 5. Heparin neutralization by recombinant platelet factor 4 and protamine.
    Levy JH, Cormack JG, Morales A.
    Anesth Analg; 1995 Jul 01; 81(1):35-7. PubMed ID: 7598278
    [Abstract] [Full Text] [Related]

  • 6. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes.
    Cook JJ, Niewiarowski S, Yan Z, Schaffer L, Lu W, Stewart GJ, Mosser DM, Myers JA, Maione TE.
    Circulation; 1992 Mar 01; 85(3):1102-9. PubMed ID: 1537108
    [Abstract] [Full Text] [Related]

  • 7. Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.
    Sasaki E, Minamiguchi K, Kitazato KT, Nagase H, Kitazato K.
    Haemostasis; 1997 Mar 01; 27(4):174-83. PubMed ID: 9483172
    [Abstract] [Full Text] [Related]

  • 8. Influence of platelet factor 4 on the neutralization of heparin by protamine.
    Shanberge JN, Quattrociocchi-Longe TM.
    Ann N Y Acad Sci; 1989 Mar 01; 556():354-65. PubMed ID: 2735664
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM, Mackie IM.
    Thromb Res; 2009 May 01; 124(1):149-55. PubMed ID: 19195682
    [Abstract] [Full Text] [Related]

  • 10. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN, Fukui H.
    J Lab Clin Med; 1967 Jun 01; 69(6):927-37. PubMed ID: 6025496
    [No Abstract] [Full Text] [Related]

  • 11. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins.
    Harenberg J, Siegele M, Dempfle CE, Stehle G, Heene DL.
    Thromb Haemost; 1993 Dec 20; 70(6):942-5. PubMed ID: 8165616
    [Abstract] [Full Text] [Related]

  • 12. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS, Rozkin MIa, Poberiĭ IA, Lindner DP.
    Farmakol Toksikol; 1981 Dec 20; 44(1):80-5. PubMed ID: 7262304
    [Abstract] [Full Text] [Related]

  • 13. Effects of a heparin-binding protein on blood coagulation and platelet function.
    Kaiser P, Harenberg J, Walenga JM, Huhle G, Giese C, Prechel M, Hoppensteadt D, Fareed J.
    Semin Thromb Hemost; 2001 Oct 20; 27(5):495-502. PubMed ID: 11668419
    [Abstract] [Full Text] [Related]

  • 14. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP, Castellani WJ, Hodges ED, Yelverton S.
    Thromb Haemost; 1991 Aug 01; 66(2):213-7. PubMed ID: 1771614
    [Abstract] [Full Text] [Related]

  • 15. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME, Angchaisuksiri P, Carr SL, Martin EJ.
    Cell Biochem Biophys; 2003 Aug 01; 39(2):89-99. PubMed ID: 14515016
    [Abstract] [Full Text] [Related]

  • 16. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W, Worowski K.
    Acta Haematol Pol; 1982 Aug 01; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract] [Full Text] [Related]

  • 17. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar 01; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 18. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.
    Dehmer GJ, Lange RA, Tate DA, Pirwitz M, Daniel W, Fisher M, Bonnem EM.
    Circulation; 1996 Nov 01; 94(9 Suppl):II347-52. PubMed ID: 8901773
    [Abstract] [Full Text] [Related]

  • 19. Neutralisation of heparan sulphate and low molecular weight heparin by protamine.
    Hubbard AR, Jennings CA.
    Thromb Haemost; 1985 Feb 18; 53(1):86-9. PubMed ID: 3158095
    [Abstract] [Full Text] [Related]

  • 20. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein.
    Kazama Y, Koide T.
    Thromb Haemost; 1992 Jan 23; 67(1):50-5. PubMed ID: 1319617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.